Alzheimer disease therapy—moving from amyloid-β to tau
E Giacobini, G Gold - Nature Reviews Neurology, 2013 - nature.com
Disease-modifying treatments for Alzheimer disease (AD) have focused mainly on reducing
levels of amyloid-β (Aβ) in the brain. Some compounds have achieved this goal, but none …
levels of amyloid-β (Aβ) in the brain. Some compounds have achieved this goal, but none …
Alzheimer disease therapy--moving from amyloid-β to tau.
E Giacobini, G Gold - Nature reviews. Neurology, 2013 - europepmc.org
Disease-modifying treatments for Alzheimer disease (AD) have focused mainly on reducing
levels of amyloid-β (Aβ) in the brain. Some compounds have achieved this goal, but none …
levels of amyloid-β (Aβ) in the brain. Some compounds have achieved this goal, but none …
Alzheimer disease therapy--moving from amyloid-[beta] to tau
E Giacobini, G Gold - Nature Reviews Neurology, 2013 - go.gale.com
Disease-modifying treatments for Alzheimer disease (AD) have focused mainly on reducing
levels of amyloid-[beta](A [beta]) in the brain. Some compounds have achieved this goal, but …
levels of amyloid-[beta](A [beta]) in the brain. Some compounds have achieved this goal, but …
[引用][C] Alzheimer disease therapy—moving from amyloid-β to tau
E Giacobini, G Gold - Nature Reviews Neurology, 2013 - cir.nii.ac.jp
Alzheimer disease therapy--moving from amyloid-β to tau
E Giacobini, G Gold - Nature reviews. Neurology, 2013 - pubmed.ncbi.nlm.nih.gov
Disease-modifying treatments for Alzheimer disease (AD) have focused mainly on reducing
levels of amyloid-β (Aβ) in the brain. Some compounds have achieved this goal, but none …
levels of amyloid-β (Aβ) in the brain. Some compounds have achieved this goal, but none …
Alzheimer disease therapy--moving from amyloid-[beta] to tau
E Giacobini, G Gold - Nature Reviews. Neurology, 2013 - search.proquest.com
Disease-modifying treatments for Alzheimer disease (AD) have focused mainly on reducing
levels of amyloid-β (Aβ) in the brain. Some compounds have achieved this goal, but none …
levels of amyloid-β (Aβ) in the brain. Some compounds have achieved this goal, but none …
Alzheimer disease therapy--moving from amyloid-β to tau.
E Giacobini, G Gold - Nature reviews. Neurology, 2013 - sonar.ch
English Disease-modifying treatments for Alzheimer disease (AD) have focused mainly on
reducing levels of amyloid-β (Aβ) in the brain. Some compounds have achieved this goal …
reducing levels of amyloid-β (Aβ) in the brain. Some compounds have achieved this goal …